Alkem Laboratories Gestione
Gestione criteri di controllo 1/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Vikas Gupta
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | 1.2yrs |
| Proprietà del CEO | n/a |
| Durata media del management | 1.2yrs |
| Durata media del Consiglio di amministrazione | 7.2yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Alkem Laboratories Limited Recorded A 5.4% Miss On Revenue: Analysts Are Revisiting Their Models
Nov 16
Here's Why We Think Alkem Laboratories (NSE:ALKEM) Is Well Worth Watching
Nov 15What Alkem Laboratories Limited's (NSE:ALKEM) P/E Is Not Telling You
Sep 24Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 03Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 13Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 27Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00
Jul 13Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jun 27Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00
Jun 13Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
Jun 01Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)
May 22Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets
Feb 13Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects
Jan 17We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease
Dec 27Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 14Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Aug 02Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Jul 07Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
May 22We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt
Mar 27Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Dec 26These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well
Sep 20Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00
Jul 27Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 13Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Jun 11Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
May 23Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Mar 06Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Feb 21AMMINISTRATORE DELEGATO
Vikas Gupta
1.2yrs
Mandato
Dr. Vikas Gupta is Chief Executive Officer of Alkem Laboratories Limited from September 22, 2023. He has experience in Pharmaceutical Sector and brings with him deep experience across therapeutic areas inc...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman | 51.3yrs | ₹200.60m | 13.31% ₹ 87.8b | |
| VP of Sales & Marketing and Executive Director | no data | ₹44.50m | 0% ₹ 0 | |
| MD & Executive Director | 1.2yrs | ₹81.50m | 0.0065% ₹ 43.1m | |
| Executive Director | no data | ₹104.30m | 8.58% ₹ 56.6b | |
| Executive Director | 2.2yrs | ₹96.60m | 0.086% ₹ 566.4m | |
| Executive Director | no data | ₹104.10m | 8.77% ₹ 57.8b | |
| Chief Executive Officer | 1.2yrs | Nessun dato | Nessun dato | |
| President & Chief Medical Officer | no data | Nessun dato | Nessun dato | |
| President & Head Medtech Business | less than a year | Nessun dato | Nessun dato | |
| President & Global HR Head | no data | Nessun dato | Nessun dato | |
| CFO & President of Finance | less than a year | Nessun dato | Nessun dato | |
| Head of Operations | no data | Nessun dato | 0.060% ₹ 396.7m |
1.2yrs
Durata media
55yo
Età media
Gestione esperta: Il team dirigenziale di ALKEM non è considerato esperto (durata media 1.2 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman | 51.3yrs | ₹200.60m | 13.31% ₹ 87.8b | |
| VP of Sales & Marketing and Executive Director | 5yrs | ₹44.50m | 0% ₹ 0 | |
| MD & Executive Director | 11.3yrs | ₹81.50m | 0.0065% ₹ 43.1m | |
| Executive Director | 16yrs | ₹104.30m | 8.58% ₹ 56.6b | |
| Executive Director | 2.2yrs | ₹96.60m | 0.086% ₹ 566.4m | |
| Executive Director | 2.9yrs | ₹104.10m | 8.77% ₹ 57.8b | |
| Independent Director | 9.7yrs | ₹3.30m | Nessun dato | |
| Independent Director | 9.4yrs | ₹3.10m | Nessun dato | |
| Independent Director | 9.4yrs | ₹3.00m | Nessun dato | |
| Independent Director | 4.7yrs | ₹3.20m | Nessun dato | |
| Independent Director | less than a year | Nessun dato | Nessun dato | |
| Independent Director | 2.3yrs | ₹2.70m | Nessun dato |
7.2yrs
Durata media
62yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di ALKEM sono considerati esperti (durata media dell'incarico 7.2 anni).